Table 2 Independent validation cohort
From: Hierarchical classification-based pan-cancer methylation analysis to classify primary cancer
Cancer type | GSE | Sample size | Auccary (%) |
|---|---|---|---|
ACC | GSE77804 | 2 | 100 |
PAAD | GSE74071 | 14 | 100 |
HNSC | GSE67114 | 8 | 100 |
LUSC | GSE121849 | 20 | 100 |
KICH | GSE156932 | 8 | 75 |
KIRC | GSE156932 | 2 | 100 |
LIHC | GSE113019 | 18 | 100 |
LUAD | GSE66836 | 164 | 100 |
SKCM | GSE140169 | 46 | 97.83 |
UVM | GSE156876 | 5 | 100 |
MESO | GSE175769 | 10 | 90 |
OV | GSE51820 | 85 | 74.12 |
PCPG | GSE43293 | 22 | 100 |
PRAD | GSE157272 | 23 | 100 |
SARC | GSE89041 | 15 | 66 |
THYM | GSE94769 | 11 | 72 |
THCA | GSE77804 | 11 | 81.82 |
BRCA | GSE52865 | 40 | 97.50 |